Skip to main content
Fig. 1 | Biomarker Research

Fig. 1

From: Prognostic and predictive biomarkers for response to neoadjuvant chemoradiation in esophageal adenocarcinoma

Fig. 1

Survival estimates based on response to neoadjuvant chemotherapy and tumor mutation count in EAC. Kaplan–Meier plots of responder and non-responder group of patients for neoadjuvant chemotherapy (A) relapse-free survival (B) overall survival. Kaplan–Meier plots of low and high tumor mutation count based on median tumor mutation count of the cohort (C) relapse-free survival (D) overall survival. Here, TMC is tumor mutation count

Back to article page

Biomarker Research

ISSN: 2050-7771

Contact us